Woman Awarded $75M for Cancer-Prempro Link

The pharmaceutical drug PREMPRO, one of many brands of estrogen-progestin pills prescribed to provide women with relief from menopausal symptoms, are seen June 26, 2003 in New York City. New analyses state estrogen-progestin pills may cause an aggressive form of breast cancer and makes finding tumors more difficult. (Photo by Stephen Chernin/Getty Images)
Getty Images
A jury in Philadelphia has ordered Wyeth Pharmaceuticals to pay a woman $75 million in punitive damages after finding a link between her breast cancer and a hormone-replacement drug.

That's according to an attorney for the woman, Connie Barton.

Last month, the jury awarded Barton $3.75 million in compensatory damages and found Wyeth willfully hid evidence of a cancer link.

The punitive award for Barton, of Peoria, Ill., had been sealed until Monday because of another Prempro case under way in the same courthouse.

A spokesman for Pfizer Inc., which recently acquired Wyeth, says the company will challenge the Barton verdict, and another verdict also announced Monday.

Barton's case is one of a handful of Prempro lawsuits to go to trial out of several thousand filed across the country.